# FDA Approves Janssen Biotech's Ustekinumab Intravenous Formulation Janssen Biotech, Inc. received FDA approval for an intravenous formulation of us...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Nuvaila Limited has received FDA approval for the injection adalimumab-atto, a subcutaneous formulation of the brand drug Amjevita. This launch signif...
Janssen Pharmaceuticals, Inc. secured FDA approval for the brand-name formulation of Invokamet XR (canagliflozin and metformin hydrochloride) today, e...
Lannett Company, Inc. received approval from the FDA to manufacture a generic version of Suboxone Film, combining buprenorphine and naloxone for subli...
Aiping Pharm Inc announced on August 26, 2016, that it received FDA approval for its ANDA #204754, granting the company authorization to commercialize...
The FDA has granted final approval to Exelan Pharmaceuticals Inc. for its ANDA for bupropion hydrochloride, setting the stage for increased generic co...
Sun Pharmaceutical Industries secured FDA approval for a generic medication under ANDA205634, a development expected to strengthen the company’s compe...
Naloxone and buprenorphine tablets, sold under the brand name Buprenex by Sun Pharmaceutical Industries, Inc., were granted FDA approval on August 5, ...
Amneal Pharmaceuticals has secured FDA approval for methylphenidate hydrochloride, the generic version of the widely prescribed attention-deficit hype...
# FDA Approves Sanofi-Aventis Biologic Drug The U.S. Food and Drug Administration has approved a new biologic drug from Sanofi-Aventis US (BLA208471)...
On July 19, Rising Pharma Holdings, Inc. announced the FDA approval of its generic version of rosuvastatin calcium, placing the company in a competiti...
Glenmark Pharmaceuticals Inc. USA has received FDA approval for the oral route rosuvastatin calcium ANDA, entering the generic market for the highly p...
SUN PHARMaceuticals has received approval for the new drug application #ANDA079169, a development that is poised to expand the company’s footprint in ...
Trigen Laboratories, LLC announced the FDA approval of its ANDA for oral hydromorphone hydrochloride tablets, adding a new generic entrant to the stro...
Stride Pharma International announced approval of its Abbreviated New Drug Application (ANDA) on July 5, 2016, indicating regulatory clearance to ente...
Amneal Pharmaceuticals NY LLC secured final FDA approval on June 27, 2016, for its Abbreviated New Drug Application (ANDA207289) of the broad-spectrum...
On June 23, Mylan Pharmaceuticals Inc. was granted FDA approval for the Abbreviated New Drug Application #ANDA204475 for tablet and capsule forms of F...
Ingenus Pharmaceuticals announced today that it received FDA approval for the ANDA206043, granting market exclusivity to its generic version of Primaq...
Lupin announced in June 2016 the approval of its ANDA 203339, signaling the company’s continued expansion into [specific therapeutic area] following t...
Strides Pharma Science Limited announced the FDA approval of its generic Hydrocodone Bitartrate and Acetaminophen products, a move anticipated to invi...